# Presbyterian Hospital Blood Bank – FDA Inspection, Mar 30, 2017

Source: https://www.keypedia.com/records/fda_inspections/presbyterian-hospital-blood-bank/5439dfa8-c387-49e4-93ac-f07f22cfc705
Source feed: FDA_Inspections

> FDA inspection 1020801 of Presbyterian Hospital Blood Bank, March 30, 2017. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 606. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1020801
- Company Name: Presbyterian Hospital Blood Bank
- Inspection Date: 2017-03-30
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1247869 - 2024-07-24
- FDA Inspection 1079363 - 2019-01-23
- FDA Inspection 916671 - 2015-03-11
- [FDA Inspection 841949 - 2013-07-18](https://www.keypedia.com/records/fda_inspections/presbyterian-hospital-blood-bank/8f7324b0-607f-4f4f-bf89-b50e9cc3e58f)
- FDA Inspection 727932 - 2011-04-29

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/gloria-a-milster/22f95276-6f68-467d-8d52-5c028c118123)

Company: https://www.keypedia.com/companies/presbyterian-hospital-blood-bank/9663e602-0f9b-4d36-aef6-cc5bfa356dde

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d